-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Moderna, Raises Price Target to $200

Benzinga·11/17/2026 11:48:01
Listen to the news
Morgan Stanley analyst Terence Flynn maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from $95 to $200.